Treatment of white patches with 4 Unani formulations

Preliminary evaluation of four Coded Unani formulations â?? UNIM-044, 045, 046, 047 (oral and topical) in cases of Bars (Vitiligo)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014096

Enrollment

120

Registered

2018-05-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vitiligo (Any type)

Interventions

Intervention1: Group-A: UNIM-044(O), UNIM044(L): UNIM-044(O) +044(L): Two capsules (500 mg each) of UNIM-044(O) were given orally twice daily an hour after meals. Ointment of UNIM-044(L) was applied o

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with clinically diagnosed Vitiligo. 2. Age â?? 8 to 60 years 3. Either gender 4. With any duration of disease, site, extension and distribution of lesions. 5. Willingness to give written consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with Hepato-renal, cardiac and pulmonary malfunction. 2. Patients on active Vitiligo treatment with other drugs/systems. 3. Subjects with other skin disease. 4. Subjects with known allergies 5. Subjects those who are unwilling to come for regular follow-ups for the entire duration of study. 6. Non-co-operative patients. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Response is assessed in the form of percentage and gradingTimepoint: Baseline, 1st month, 2nd month, 3rd month, 4th month, 5th month, 6th month, 7th month, 8th month, 10th month and 12th month	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr M A Samad

Central Research Institute of Unani Medicine

ahmedminhajuddin@yahoo.com9177376011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026